- Home
- OKUR
OKUR
ONKURE THERAPEUTICS INC
as 12-26-2024 9:55am EST
Stocks
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | BOULDER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $36.00 | AVG Volume (30 days): | 151.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.35 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.69 - $20.00 | Next Earning Date: | 02-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest ONKURE THERAPEUTICS INC News
OKUR Breaking Stock News: Dive into OKUR Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
GlobeNewswire
a month ago
OnKure Announces New Date for Upcoming Investor Call
GlobeNewswire
2 months ago
OnKure to Present at the Stifel 2024 Healthcare Conference
GlobeNewswire
2 months ago
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
Compare OKUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OKUR ONKURE THERAPEUTICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.